Evidence map›Paper›PMID 21417722›Full record

ReviewAnnual review of biomedical engineering2011

Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds.

Stephen F Badylak, Doris Taylor, Korkut Uygun

Abstract readReview
In one paragraph

Review in Annual review of biomedical engineering, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 410 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
410citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

410 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

350 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stephen F BadylakDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA. badylaks@upmc.edu
Doris Taylor
Korkut Uygun

Funding

Midwestern Progenitor Cell ConsortiumU01HL100407 · NHLBI · UNIVERSITY OF MINNESOTA · PI GARRY, DANIEL J., KYBA, MICHAEL · 2009 to 2015
$7.8M
Computer-aided Development of a Liver Organ Culture SystemR00DK080942 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, KORKUT · 2010 to 2012
$900k
Computer-aided Development of a Liver Organ Culture SystemK99DK080942 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI UYGUN, KORKUT · 2008 to 2009
$181k
NHLBI NIH HHS 1U01HL100407-0NHLBI NIH HHS U01 HL100407NIDDK NIH HHS DK080942NIDDK NIH HHS K99 DK080942NIDDK NIH HHS R00 DK080942
6 · The paper itself

Abstract

The definitive treatment for end-stage organ failure is orthotopic transplantation. However, the demand for transplantation far exceeds the number of available donor organs. A promising tissue-engineering/regenerative-medicine approach for functional organ replacement has emerged in recent years. Decellularization of donor organs such as heart, liver, and lung can provide an acellular, naturally occurring three-dimensional biologic scaffold material that can then be seeded with selected cell populations. Preliminary studies in animal models have provided encouraging results for the proof of concept. However, significant challenges for three-dimensional organ engineering approach remain. This manuscript describes the fundamental concepts of whole-organ engineering, including characterization of the extracellular matrix as a scaffold, methods for decellularization of vascular organs, potential cells to reseed such a scaffold, techniques for the recellularization process and important aspects regarding bioreactor design to support this approach. Critical challenges and future directions are also discussed.

Indexed as

Amniotic FluidAnimalsBioreactorsCells, CulturedEmbryonic Stem CellsExtracellular MatrixFetal BloodHumansInduced Pluripotent Stem CellsOrgan Culture TechniquesTissue EngineeringTissue Scaffolds

Identifiers

PMID21417722
PMCPMC10887492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.